Brief: Orexo Expects FDA Filing Of OX124 Mid 2022
29/01/2021 15:54
Jan 29 (Reuters) - Orexo AB ORX.ST :
* OREXO EXPECTS FDA FILING OF OX124 MID 2022
* IF APPROVED, OX124 IS ESTIMATED TO HAVE A SALES POTENTIAL
OF USD
70 - 110 MILLION
Source text for Eikon: ID:nWkrb3DyVp
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))